References
- Ellenhorn M. J., Barceloux D. G. Medical Toxicology. Elsevier, New York 1998; 200–208
- Berlinger W. G., Spector R., Goldberg M. J., Johnson G. F., Quee C. K., Berg M. J. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther 1983; 33: 351–354
- Brown S. G., Prentice D. A. Ondansetron in the treatment of theophylline overdose. Med J Austr 1992; 156: 512
- Cold J. A., Wells B. G., Froemming J. H. Seizure activity associated with anticonvulsant therapy. DICP 1990; 24: 601–606
- Jick H., Slone D., Shapiro S., et al. Drug‐induced convulsions: report from Boston Collaborative Drug Surveillance Program. Lancet 1972; 2: 677–679
- Gunning S. J., Hagan R. M., Tyers M. B. Cisplatin induced biochemical and histological changes in the small intestine of the ferret. Br J Pharmacol 1987; 90: 135P
- Ireland S. J., Tyers M. B. Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 1987; 90: 229–238
- Tyers M. B., Bunce K. T., Humphrey P. P. Pharmacological and anti‐emetic properties of ondansetron. Eur J Cancer Clin Oncol 1989; 25: S15–S19
- Larijani G. E., Gratz I., Afshar M., Minassian S. Treatment of postoperative nausea and vomiting with ondansetron;a randomized double‐blind comparison with placebo. Anesth Analg 1991; 73: 246–249
- Priestman T. J. Clinical studies with ondansetron in the control of radiation‐induced emesis. Eur J Cancer Clin One 1989; 25: S29–S33
- Gandara D. R. Progress in the control of acute and delayed emesis induced by cisplatin. Eur J Cancer 1991; 27: S9–S11
- Mitchell P. L., Evans B. D., Allen S. G., et al. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics. N Z Med J 1992; 105: 73–75
- Higgins G. A., Kilpatrick G. J., Bunce K. T., Jones B. J., Tyers M. B. 5HT3 receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret. Br J Pharmcol 1989; 97: 247–255
- Blackwell C. P., Harding S. M. The clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 1989; 25: S21–S24
- Hsyu P. H., Pritchard J. F., Bozigian H. P., et al. Oral ondansetron pharmacokinetics: the effects of chemotherapy. J Clin Pharmacol 1994; 34: 767–773
- Ashforth E. I., Palmer J. L., Bye A., Bedding A. The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolizers of debrisoquine. Br J Clin Pharmacol 1994; 37: 389–391
- Cubeddu L. X., Hoffmann I. S., Fuenmayor N. T., Finn A. L. Efficacy of ondansetron (GR38032F) and the role of serotonin in ciplatin‐induced nausea and vomiting. NEnglJ Med 1990; 322: 810–816
- De Mulder P. H., Seynaeve C., Vermorken J. B., et al. Ondansetron compared with high dose metacloprami de in prophylaxis of acute and delayed ciplatin‐induced nausea and vomiting. A multicenter, randomized, double‐blind crossover study. Ann Intern Med 1990; 113: 834–840
- Kaasa S., Kvaloy S., Dicato M. A., et al. A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy‐induced nausea and vomiting: a randomized, double‐blind study. Eur J Cancer 1990; 26: 311–314
- Smith R. N. Safety of ondansetron. Eur J Cancer Clin Oncol 1989; 25: S47–S50
- Tucker M. L., Jackson M. R., Scales M. D., Spurting N. W., Iweats D. J., Capel‐Edwards K. Ondansetron: preclinical safety evaluation. Eur J Cancer Clin Oncol 1989; 25: S79–S93
- Package insert, Zofran®. Cerenex, Research Triangle Park, NC
- Krstenansky P. M., Petree J., Long G. Extrapyramidal reaction caused by ondansetron. Ann Pharmacother 1994; 28: 280
- Dobrow R. B., Coppock M. A., Hosenpud J. R. Extrapyramidal reaction caused by ondansetron. J Oin Oncol 1991; 9: 1921
- Halperin J. R., Murphy B. Extrapyramidal reaction to ondansetron. Cancer 1992; 69: 1275
- Sargent A. I., Deppe S. A., Chan F. A. Seizure associated with ondansetron. Clin Pharm 1993; 12: 613–615
- Sage T. A., Jones W. N., Clark R. F. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity. Ann Pharmacother 1993; 27: 584–585
- Reed M. D., Marx C. M. Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmacother 1994; 28: 331–333